Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

Quest Diagnostics Introduces bioMerieux THxID®-BRAF Test
Wednesday, June 11, 2014
A companion diagnostic to advance precision medicine for melanoma.

Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
Tuesday, June 03, 2014
Final results demonstrate a very good safety, treatment feasibility and promising signs of efficacy in patients with advanced Soft Tissue Sarcomas.

Nodality Announces Publication of Promising Data in Melanoma in JTM
Friday, May 30, 2014
Nodality's SCNP platform holds strong potential in aiding the development of new cancer and immuno-oncology treatments.

New Cancer Diagnostic Device
Thursday, May 29, 2014
Commercial launch of a new system to improve cancer diagnosis and treatment.

Debiopharm Moves Forward Three of its Oncology Clinical Programs
Thursday, May 29, 2014
Company will present the recent progresses at the 50th American Society of Clinical Oncology Annual Meeting.

Powerful Tool for Genomic Editing
Friday, May 23, 2014
CRISPR/Cas9 - Designed to produce a genetically modified cell.

Next-Generation Flow Cytometry Instrument Broadens Analysis in Life Science Research
Thursday, May 22, 2014
Life Technologies Attune NxT Acoustic Focusing Cytometer expands capabilities, features modular design to fit any lab’s budget and research.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 655
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv